Trends in Erythropoiesis-stimulating agent use and blood transfusions for chemotherapy-induced anemia throughout FDA's risk evaluation and mitigation strategy lifecycle.
Pharmacoepidemiol Drug Saf
; 30(5): 626-635, 2021 05.
Article
in En
| MEDLINE
| ID: mdl-33534188
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Hematinics
/
Anemia
/
Antineoplastic Agents
Type of study:
Etiology_studies
/
Observational_studies
/
Risk_factors_studies
Limits:
Aged
/
Humans
Country/Region as subject:
America do norte
Language:
En
Journal:
Pharmacoepidemiol Drug Saf
Journal subject:
EPIDEMIOLOGIA
/
TERAPIA POR MEDICAMENTOS
Year:
2021
Document type:
Article
Affiliation country:
Country of publication: